None listed
Conditions
Brief summary
The primary purpose of this observational study is to check whether frailty predicts mortality/death in patients who are in the hospital for an upper gastrointestinal bleeding (UGIB) episode. We hypothesize that frailty is an independent predictor of death in patients with UGIB and other important hospital outcomes.
Interventions
Assessing the role of frailty as measured by the Canadian Study of Health and Ageing (CSHA) clinical frailty scale, age, and other risk scores (Charles comorbidity index, Glasgow Blatchford score, AIMS 65 score) in predicting mortality in consecutive patients with upper gastrointestinal bleed over 21 months.
The score of frailty is assigned by an investigator at the time of upper GI bleed from an overall clinical assessment after their informed consent. The rest of the data is collected from the
Assessing the role of frailty as measured by the Canadian Study of Health and Ageing (CSHA) clinical frailty scale, age, and other risk scores (Charles comorbidity index, Glasgow Blatchford score, AIMS 65 score) in predicting mortality in consecutive patients with upper gastrointestinal bleed over 21 months. The score of frailty is assigned by an investigator at the time of upper GI bleed from an overall clinical assessment after their informed consent. The rest of the data is collected from the medical records. The 30-day follow-up data is either obtained from the medical records if available or via telephone follow-up.
Sponsors
Liverpool Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Healthy volunteers
No
Inclusion criteria
Age > or = 18 years Informed consent Symptoms of Upper gastrointestinal bleed (malaena, haematemesis, coffee-ground emesis, Haematochezia)
Exclusion criteria
<18 years and >100 years no informed consent Lower Gastrointestinal bleed on endoscopic assessment Bleeding without any source on endoscopic assessment No bleeding on endoscopic assessment
Outcome results
None listed